Inmune Stock In The News

INMB
 Stock
  

USD 9.02  0.06  0.66%   

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Inmune and other traded companies coverage. We help investors stay connected with Inmune headlines for the 19th of August to make an informed investment decision based on correlating the impacts of news items on Inmune Stock performance. Please note that trading solely based on the Inmune Bio hype is not for everyone as timely availability and quick action are needed to avoid losses. As of August 19, 2022, Net Income Common Stock is expected to decline to about (31.1 M).
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Inmune Bio headlines in addition to utilizing other, more conventional financial analysis modules. Please see Inmune Bio Backtesting and Inmune Bio Hype Analysis.

Inmune Bio Today Top News and Investor Outlook

Inmune Bio Past News Timeline

Inmune Bio's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Inmune Bio investors visualize upcoming and past events in order to time the market based on Inmune Bio noise-free hype analysis.
Inmune Bio stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Inmune earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Inmune Bio that are available to investors today. That information is available publicly through Inmune media outlets and privately through word of mouth or via Inmune internal channels. However, regardless of the origin, that massive amount of Inmune data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inmune Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inmune Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inmune Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inmune Bio alpha.

Inmune Largest EPS Surprises

Earnings surprises can significantly impact Inmune Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-03-29
2018-12-31-0.19-0.21-0.0210 
2020-03-11
2019-12-31-0.25-0.220.0312 
2021-05-05
2021-03-31-0.27-0.32-0.0518 
2021-03-04
2020-12-31-0.31-0.260.0516 
2019-11-08
2019-09-30-0.19-0.28-0.0947 
2021-08-04
2021-06-30-0.34-0.44-0.129 
View All Earnings Estimates

Inmune Bio Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Inmune Bio Stock. The global stock market is bearish. About 66% of major world exchanges and indexes are down. See today's market update for more information.
news
3rd of August 2022
EPS Reported
at EPS REPORTED 
news
27th of July 2022
Financial Statements
at SEC 
Macroaxis News: marketscreener.com
25th of July 2022
INmune Bio Alzheimers Association International Conference Systems Biology of Alzheimers D...
at www.marketscreener.com 
Simply Wall St News at Macroaxis
11th of July 2022
Heres Why INmune Bio Can Manage Its Debt Despite Losing Money - Simply Wall St
at simplywall.st 
news
30th of June 2022
EPS Estimate
at EPS ESTIMATE 
news
23rd of June 2022
Financial Statements
at SEC 
news
16th of June 2022
Financial Statements
at SEC 
benzinga news
15th of June 2022
SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of INmune ...
at www.benzinga.com 
news
1st of June 2022
Filing
at SEC 
news
31st of May 2022
Purchase by Tesi Raymond Joseph of 6300 shares of Inmune Bio
at Tesi Raymond Joseph 
news
24th of May 2022
Financial Statements
at SEC 

Inmune Bio Investors Sentiment

The influence of Inmune Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Inmune. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Inmune Bio's public news can be used to forecast risks associated with investment in Inmune. The trend in average sentiment can be used to explain how an investor holding Inmune can time the market purely based on public headlines and social activities around Inmune Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Inmune Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Inmune Bio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Inmune Bio's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Inmune Bio.

Inmune Bio Implied Volatility

    
  254.6  
Inmune Bio's implied volatility exposes the market's sentiment of Inmune Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Inmune Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Inmune Bio stock will not fluctuate a lot when Inmune Bio's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Inmune Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Inmune Bio's short interest history, or implied volatility extrapolated from Inmune Bio options trading.
Please see Inmune Bio Backtesting and Inmune Bio Hype Analysis. Note that the Inmune Bio information on this page should be used as a complementary analysis to other Inmune Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Inmune Stock analysis

When running Inmune Bio price analysis, check to measure Inmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmune Bio is operating at the current time. Most of Inmune Bio's value examination focuses on studying past and present price action to predict the probability of Inmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmune Bio's price. Additionally, you may evaluate how the addition of Inmune Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Inmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmune Bio. If investors know Inmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
162.9 M
Quarterly Revenue Growth YOY
39.75
Return On Assets
-0.26
Return On Equity
-0.58
The market value of Inmune Bio is measured differently than its book value, which is the value of Inmune that is recorded on the company's balance sheet. Investors also form their own opinion of Inmune Bio's value that differs from its market value or its book value, called intrinsic value, which is Inmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmune Bio's market value can be influenced by many factors that don't directly affect Inmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Inmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.